S
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®.
Investor insights
Funding rounds participated in
$32M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1996
Funding rounds raised
Total raised
$32M
from investors over 1 rounds
S
Starpharma raised $32M on October 30, 2020